Antispasmodic agents for radial artery conduit in CABG

Antispasmodic agents for radial artery conduit in CABG - Antispasm Radial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38886

Enrollment

Registered

2013-09-25

Start date

2013-10-14

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasm

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients undergoing isolated or combined CABG whereby the radial artery is used as a conduit with or without the use of other conduits.

Exclusion criteria

Exclusion criteria: Emergency operations

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: The main endpoint of the study is the mean amount of free flow through the radial artery conduit. This is measured directly after harvesting the radial artery by allowing a free flow of both solution through the conduit into an empty bowl. The mean amount of the solution (in ml) collected in one minute is calculated. This is considered as the mean free flow (ml/min) through the conduit.	—

Measure

Time frame

Main study parameters/endpoints: The main endpoint of the study is the mean amount of free flow through the radial artery conduit. This is measured directly after harvesting the radial artery by allowing a free flow of both solution through the conduit into an empty bowl. The mean amount of the solution (in ml) collected in one minute is calculated. This is considered as the mean free flow (ml/min) through the conduit.

—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results